Lilly expands access to Zepbound weight-loss drug with $299 monthly self-pay option
The expanded program allows patients to fill prescriptions either at a local pharmacy or through home delivery via LillyDirect
The expanded program allows patients to fill prescriptions either at a local pharmacy or through home delivery via LillyDirect
Patients can now get the starting 2.5 mg dose for $299 per month
Basketball legend, entrepreneur, and entertainer Shaquille O’Neal partners with Lilly to encourage Americans to recognize the signs of obstructive sleep apnea and talk to their
Walmart, with nearly 4,600 pharmacies nationwide, will serve as the first in-store pickup pharmacy for LillyDirect's self-pay single-dose vials
Tirzepatide is a prescription based the first and only dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors
Adults taking Mounjaro with diet and exercise in a controlled clinical trial lost on average 21.8 kg at the highest dose (15mg) and 15.4 kg at the lowest dose (5mg)
PROVIGIL and NUVIGIL are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy
Express Scripts to add Zepbound to National Preferred Formulary
Lilly to further investigate retatrutide for the treatment of obesity in the TRIUMPH phase 3 clinical program
Study to evaluate effectiveness of hypoglossal nerve stimulation
Subscribe To Our Newsletter & Stay Updated